Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.92 | 1.03 | 0.11 |
Shares | 99.08 | 99.08 | 0.00 |
Other | 0.01 | 0.01 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 19.24 | 21.94 |
Price to Book | 4.16 | 4.16 |
Price to Sales | 2.44 | 2.42 |
Price to Cash Flow | 17.43 | 17.25 |
Dividend Yield | 1.84 | 1.31 |
5 Years Earnings Growth | 10.18 | 13.24 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.37 | 95.09 |
Basic Materials | 0.53 | 1.56 |
Financial Services | 0.05 | 9.21 |
Consumer Defensive | 0.05 | 3.65 |
Number of long holdings: 198
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.26 | 806.14 | -1.56% | |
UnitedHealth | US91324P1021 | 6.04 | 557.77 | -1.72% | |
J&J | US4781601046 | 5.07 | 158.24 | -1.18% | |
Novo Nordisk B | DK0062498333 | 4.89 | 752.6 | -2.12% | |
Merck&Co | US58933Y1055 | 4.23 | 101.87 | -0.01% | |
AbbVie | US00287Y1091 | 4.07 | 200.47 | -1.51% | |
Thermo Fisher Scientific | US8835561023 | 2.87 | 555.47 | -0.44% | |
Novartis | CH0012005267 | 2.76 | 95.58 | +0.09% | |
Abbott Labs | US0028241000 | 2.70 | 117.65 | -0.80% | |
Roche Holding Participation | CH0012032048 | 2.44 | 272.30 | -0.29% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Legal General US Index Trust I Acc | 1.57B | 7.04 | 14.13 | 15.25 | ||
Legal General US Index Trust I Dist | 1.68B | 7.05 | 14.13 | 15.25 | ||
Legal General US Index Trust C Acc | 3.47B | 14.61 | 10.47 | 14.99 | ||
Legal General US Index Trust C Dist | 825.06M | 14.53 | 10.45 | 14.98 | ||
Legal General US Index Trust F Acc | 526.62K | 14.34 | 10.15 | 14.66 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review